mecamylamine has been researched along with Leukemia, Promyelocytic, Acute in 1 studies
Mecamylamine: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.
Leukemia, Promyelocytic, Acute: An acute myeloid leukemia in which abnormal PROMYELOCYTES predominate. It is frequently associated with DISSEMINATED INTRAVASCULAR COAGULATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Landais, E | 1 |
| El-Khoury, V | 1 |
| Prevost, A | 1 |
| Dufer, J | 1 |
| Liautaud-Roger, F | 1 |
1 other study available for mecamylamine and Leukemia, Promyelocytic, Acute
| Article | Year |
|---|---|
Nicotine induces chromatin changes and c-Jun up-regulation in HL-60 leukemia cells.
Topics: Acetylation; Cell Nucleus; Chromatin; Dose-Response Relationship, Drug; Gene Expression; Histones; H | 2005 |